Protein Superglue! What This Means for Drug Discovery?

There is a history of unequal access to health care for many groups. In this live panel discussion, Johns Hopkins scientists discuss bias in medicine and address what can be done to give everyone the opportunity to live a healthy life.

In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.

In this episode, we speak with Tomasz Kostrzewski, Director of Biology at CN Bio about how drugs are developed, including the challenges faced when designing and developing a drug, how drug discovery has evolved, and what trends we can expect to see in the future.